Integration of the human immunodeficiency virus (HIV-1) cDNA into the human genome is catalysed by integrase. Several studies have shown the importance of the interaction of cellular cofactors with integrase for viral integration and infectivity. In this study, we produced a stable and functional complex between the wild-type full-length integrase (IN) and the cellular cofactor LEDGF/p75 that shows enhanced in vitro integration activity compared with the integrase alone. Mass spectrometry analysis and the fitting of known atomic structures in cryo negatively stain electron microscopy (EM) maps revealed that the functional unit comprises two asymmetric integrase dimers and two LEDGF/p75 molecules. In the presence of DNA, EM revealed the DNA-binding sites and indicated that, in each asymmetric dimer, one integrase molecule performs the catalytic reaction, whereas the other one positions the viral DNA in the active site of the opposite dimer. The positions of the target and viral DNAs for the 3 0 processing and integration reaction shed light on the integration mechanism, a process with wide implications for the understanding of viral-induced pathologies.

An analytical strategy for the analysis of antigen epitopes by chemical cross-linking and mass spectrometry is demonstrated. The information of antigen peptides involved in the binding to an antibody can be obtained by monitoring the antigen peptides modified by a partially hydrolyzed cross-linker in the absence and in the presence of an antibody. This approach was shown to be efficient for characterization of the epitope on bovine prion protein bPrP(25-241) specifically recognized by a monoclonal antibody, 3E7 (mAb3E7), with only a small amount of sample (200 picomoles) needed. After cross-linking of the specific immuno complex, a matrix-assisted laser desorption/ionization (MALDI) mass spectrometer equipped with an ion conversion dynode (ICD) high-mass detector was used to optimize the amount of cross-linked complex formed at 202 kDa before proteolytic digestion. To identify the cross-linked peptides after proteolysis without ambiguity, isotope-labeled cross-linkers, disuccinimidyl suberate (DSS-d0/d12) and disuccinimidyl glutarate (DSG-d0/d6), together with high-resolution Fourier transform ion-cyclotron resonance mass spectrometry (FTICR-MS) were used. As a result, a complete fading of the peak intensities corresponding to the peptides representing the epitope was observed when bPrP/mAb3E7 complexes were formed.

A rapid, specific, and sensitive method for the detection of protein-protein interactions is of crucial importance for drug discovery and clinical diagnostics. Mass spectrometry plays a major role in the analysis of proteins, but its application to the routine analysis of protein complexes has been lagging behind. A new strategy for high-throughput analysis of protein interactions is presented here. We demonstrate application to immunochemical questions such as epitope mapping, kinetic studies, and sandwich assays. The methodology is based on a direct mass spectrometric readout for antigen-antibody complexes in the 150-400 kDa range. This has become possible using a novel detector technology and chemical cross-linking to stabilize complexes for analysis by MALDI MS. We demonstrate high detection sensitivity (femtomole quantities of antigen), high specificity (specific detection of antigen directly in serum), high accuracy, and high speed (minutes per assay), surpassing conventional analytical methods by more than 2 orders of magnitude.

The triggering receptor expressed on myeloid cells-1 (TREM-1) is a receptor expressed on innate immune cells. By promoting the amplification of inflammatory signals that are initially triggered by Toll-like receptors (TLRs), TREM-1 has been characterized as a major player in the pathophysiology of acute and chronic inflammatory diseases, such as septic shock, myocardial infarction, atherosclerosis, and inflammatory bowel diseases. However, the molecular events leading to the activation of TREM-1 in innate immune cells remain unknown. Here, we show that TREM-1 is activated by multimerization and that the levels of intracellular Ca release, reactive oxygen species, and cytokine production correlate with the degree of TREM-1 aggregation. TREM-1 activation on primary human monocytes by LPS required a two-step process consisting of upregulation followed by clustering of TREM-1 at the cell surface, in contrast to primary human neutrophils, where LPS induced a rapid cell membrane reorganization of TREM-1, which confirmed that TREM-1 is regulated differently in primary human neutrophils and monocytes. In addition, we show that the ectodomain of TREM-1 is able to homooligomerize in a concentration-dependent manner, which suggests that the clustering of TREM-1 on the membrane promotes its oligomerization. We further show that the adapter protein DAP12 stabilizes TREM-1 surface expression and multimerization. TREM-1 multimerization at the cell surface is also mediated by its endogenous ligand, a conclusion supported by the ability of the TREM-1 inhibitor LR12 to limit TREM-1 multimerization. These results provide evidence for ligand-induced, receptor-mediated dimerization of TREM-1. Collectively, our findings uncover the mechanisms necessary for TREM-1 activation in monocytes and neutrophils.

Heterotrimeric AMP-activated protein kinase (AMPK) is crucial for energy homeostasis of eukaryotic cells and organisms. Here we report on (i) bacterial expression of untagged mammalian AMPK isoform combinations, all containing ␥ 1 , (ii) an automated four-dimensional purification protocol, and (iii) biophysical characterization of AMPK heterotrimers by small angle x-ray scattering in solution (SAXS), transmission and scanning transmission electron microscopy (TEM, STEM), and mass spectrometry (MS). AMPK in solution at low concentrations (< ϳ1 mg/ml) largely consisted of individual heterotrimers in TEM analysis, revealed a precise 1:1:1 stoichiometry of the three subunits in MS, and behaved as an ideal solution in SAXS. At higher AMPK concentrations, SAXS revealed concentration-dependent, reversible dimerization of AMPK heterotrimers and formation of higher oligomers, also confirmed by STEM mass measurements. Single particle reconstruction and averaging by SAXS and TEM, respectively, revealed similar elongated, flat AMPK particles with protrusions and an indentation. In the lower AMPK concentration range, addition of AMP resulted in a significant decrease of the radius of gyration by ϳ5% in SAXS, which indicates a conformational switch in AMPK induced by ligand binding. We propose a structural model involving a ligand-induced relative movement of the kinase domain resulting in a more compact heterotrimer and a conformational change in the kinase domain that protects AMPK from dephosphorylation of Thr 172 , thus positively affecting AMPK activity.Mammalian AMP-activated protein kinase (AMPK) 4 and its orthologs found in yeast, plants, insects, invertebrates, and vertebrates are fuel sensors of the eukaryotic cell and function as master regulators of energy metabolism (1-5). AMPK is a serine/threonine protein kinase, consisting of one catalytic ␣ and two regulatory subunits (␤ and ␥), that exist as multiple isoforms (␣ 1 , ␣ 2 , ␤ 1 , ␤ 2 , ␥ 1 , ␥ 2 , ␥ 3 ) and splice variants (␥ 2 and ␥ 3 ), thus allowing for the generation of multiple heterotrimeric isoform combinations. Critical for activation of AMPK is its phosphorylation at Thr 172 in the kinase domain of the ␣-subunit by either of the two upstream kinases of AMPK, LKB1-MO25␣-STRAD␣ or Ca 2ϩ /calmodulin-dependent protein kinase kinase ␤ (CaMKK␤) (6 -10). In addition, AMP allosterically stimulates AMPK (10, 11) by binding to two pairs of CBS domains in the ␥-subunits, called Bateman domains (12). These domains were reported to show high affinity for AMP (10, 13) and lower affinity for ATP (12), although a recent study indicates that these affinities may be similar (14). AMP is a very sensitive signal for an altered cellular energy status (13,15,16). Its intracellular concentration changes by 1 order of magnitude upon a 1% change in the cellular ATP concentration, due to the equilibrium reactions of adenylate kinase and creatine kinase (5, 15-18). The latter uses phosphocreatine to rapidly rephosphorylate ADP to ATP and thus maintains a high ATP/ADP ratio (17,...